Hardman Johnston Global Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
149,855
+37,199
| +33% | +$2.57M | 0.46% | 40 |
|
|
2025
Q1 | $7.82M | Sell |
112,656
-22,304
| -17% | -$1.55M | 0.37% | 46 |
|
|
2024
Q4 | $11.6M | Sell |
134,960
-9,238
| -6% | -$795K | 0.48% | 44 |
|
|
2024
Q3 | $17.2M | Sell |
144,198
-4,580
| -3% | -$545K | 0.67% | 36 |
|
|
2024
Q2 | $21.2M | Sell |
148,778
-19,388
| -12% | -$2.77M | 0.82% | 32 |
|
|
2024
Q1 | $21.6M | Buy |
168,166
+61,620
| +58% | +$7.91M | 0.74% | 38 |
|
|
2023
Q4 | $11M | Buy |
106,546
+66,330
| +165% | +$6.86M | 0.35% | 48 |
|
|
2023
Q3 | $3.66M | Sell |
40,216
-1,730
| -4% | -$157K | 0.12% | 55 |
|
|
2023
Q2 | $3.39M | Sell |
41,946
-17,750
| -30% | -$1.44M | 0.11% | 57 |
|
|
2023
Q1 | $4.75M | Hold |
59,696
| – | – | 0.16% | 55 |
|
|
2022
Q4 | $4.04M | Hold |
59,696
| – | – | 0.16% | 57 |
|
|
2022
Q3 | $2.97M | Sell |
59,696
-18,320
| -23% | -$913K | 0.13% | 54 |
|
|
2022
Q2 | $4.35M | Buy |
78,016
+5,320
| +7% | +$296K | 0.18% | 53 |
|
|
2022
Q1 | $4.04M | Hold |
72,696
| – | – | 0.13% | 54 |
|
|
2021
Q4 | $4.07M | Buy |
72,696
+336
| +0.5% | +$18.8K | 0.11% | 52 |
|
|
2021
Q3 | $3.47M | Buy |
72,360
+1,300
| +2% | +$62.4K | 0.09% | 52 |
|
|
2021
Q2 | $2.98M | Hold |
71,060
| – | – | 0.07% | 53 |
|
|
2021
Q1 | $2.4M | Buy |
71,060
+30,500
| +75% | +$1.03M | 0.07% | 53 |
|
|
2020
Q4 | $1.42M | Hold |
40,560
| – | – | 0.04% | 58 |
|
|
2020
Q3 | $1.41M | Sell |
40,560
-36,420
| -47% | -$1.26M | 0.05% | 57 |
|
|
2020
Q2 | $2.52M | Buy |
+76,980
| New | +$2.52M | 0.11% | 54 |
|
|
2016
Q4 | – | Sell |
-465,576
| Closed | -$9.68M | – | 79 |
|
|
2016
Q3 | $9.68M | Buy |
465,576
+7,820
| +2% | +$163K | 0.44% | 46 |
|
|
2016
Q2 | $12.3M | Sell |
457,756
-27,234
| -6% | -$732K | 0.63% | 45 |
|
|
2016
Q1 | $13.1M | Buy |
+484,990
| New | +$13.1M | 0.77% | 42 |
|